Ilan Hadar

Chief Financial Officer, Foamix Pharmaceuticals Ltd.

Companies

Silexion Therapeutics CorpChief executive officer Aug 15, 2024 to now¹
Silexion Therapeutics CorpChair Aug 15, 2024 to now¹
Yarrow Bioscience, Inc.Chief financial officer Mar 11, 2020 to Mar 11, 2020²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Silexion Therapeutics Corp SLXN16,547 shares³$3.0K at $0.18Jun 4, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 4, 2026Granted 10,000 shares of Silexion Therapeutics Corp³
Feb 20, 2026Granted 64,350 shares of Silexion Therapeutics Corp⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARSilexion Therapeutics Corp, Chief executive officer
2
SEC EDGARYarrow Bioscience, Inc., Chief financial officer
3
SEC EDGARSilexion Therapeutics Corp shares after the filing of Jun 4, 2026
4
SEC EDGARForm 4 filed Feb 23, 2026